Argitalpenak (82) MIGUEL ÁNGEL GÓMEZ SÁNCHEZ argitalpenak

2021

  1. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

    Respiratory Medicine, Vol. 178

  2. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

    Respiratory Medicine, Vol. 177

2019

  1. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

2018

  1. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462

2017

  1. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study

    Journal of Heart and Lung Transplantation, Vol. 36, Núm. 5, pp. 529-539

  2. La evolución de la hipertensión arterial pulmonar a lo largo de 30 años: experiencia de un centro de referencia

    Revista Espanola de Cardiologia, Vol. 70, Núm. 11, pp. 915-923

2016

  1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    European Heart Journal, Vol. 37, Núm. 1, pp. 67-119

  2. Heart failure: A new epidemic of cardiovascular disease

    Acta Medica Portuguesa

  3. Long-Term Outcome of Patients with Chronic Thromboembolic Pulmonary Hypertension : Results from an International Prospective Registry

    Circulation, Vol. 133, Núm. 9, pp. 859-871

  4. Pulmonary arterial hypertension in systemic lupus erythematosus: Prevalence and predictors

    Journal of Rheumatology, Vol. 43, Núm. 2, pp. 323-329

2015

  1. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 34, Núm. 8, pp. 1112-1119

  2. Inoperable chronic thromboembolic pulmonary hypertension treated with riociguat: A case study

    Revista Portuguesa de Cardiologia, Vol. 34, Núm. 12, pp. 777.e1-777.e5

  3. Tromboendarterectomía pulmonar en 106 pacientes con hipertensión pulmonar tromboembólica crónica

    Archivos de Bronconeumologia, Vol. 51, Núm. 10, pp. 502-508

2014

  1. Correction: Updated clinical classification of pulmonary hypertension (Journal of the American College of Cardiology (2013) 62, (D34-D41))

    Journal of the American College of Cardiology

  2. What is the clinical significance of isolated subsegmental pulmonary embolism?

    Revista Portuguesa de Pneumologia

2013

  1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    Revista Romana de Cardiologie

  2. Erratum: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (European Journal of Heart Failure (2012) 14 (803-869))

    European Journal of Heart Failure

  3. Erratum: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (European Heart Journal (2012) 33 (1787-1847) DOI: 10.1093/eurheartj/ehs104)

    European Heart Journal

  4. Identificación de pacientes de riesgo. Criterios de elegibilidad

    Revista Espanola de Cardiologia Suplementos, Vol. 13, Núm. 4, pp. 2-6

  5. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study

    Circulation, Vol. 127, Núm. 10, pp. 1128-1138